SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-212691
Filing Date
2022-08-05
Accepted
2022-08-04 17:31:37
Documents
16
Period of Report
2022-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d317645d8k.htm   iXBRL 8-K 28894
2 EX-1.1 d317645dex11.htm EX-1.1 178303
3 EX-5.1 d317645dex51.htm EX-5.1 9708
7 GRAPHIC g317645g0804090807133.jpg GRAPHIC 3266
8 GRAPHIC g317645sp002.jpg GRAPHIC 2004
  Complete submission text file 0001193125-22-212691.txt   402044

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA allk-20220804.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allk-20220804_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allk-20220804_pre.xml EX-101.PRE 11261
10 EXTRACTED XBRL INSTANCE DOCUMENT d317645d8k_htm.xml XML 3331
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 221137915
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences